Abdera Therapeutics
PrivateLast Round
Series B
Apr 4, 2023
Total Funding Raised
$180.78M
Company Overview
Abdera Therapeutics is a biotechnology company that develops a precision oncology platform for targeted alpha radiation therapies aimed at patients with relapsed, refractory, and metastatic cancers.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Abdera Therapeutics Comparables
Compare Abdera Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Alpha-9 Oncology | 87% | |
| Radionetics Oncology | 87% | |
| Ratio Therapeutics Inc. | 84% | |
Abdera Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Apr 4, 2023 | ||||
| Seed | Jan 14, 2021 |
Key People
Founding team and executive leadership
Abdera Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Amplitude Ventures | Series B, Series A |
| Versant Ventures | Series B, Series A |
| Viking Global Investors | Series B |
| venBio | Series B |
| Qiming | Series B |
| Northview LifeSciences | Series A, Series B |
| RTW Investments | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jan 13, 2026
Presenting at the 44th Annual J.P. Morgan Healthcare Conference.
- Aug 26, 2025
Initial Phase 1 data for ABD-147 presented at IASLC 2025.
Abdera Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Abdera Therapeutics's valuation, stock price, and market status.